Cargando…

Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment

Pexa-Vec (pexastimogene devacirpvec; JX-594) has emerged as an attractive tool in oncolytic virotherapy. Pexa-Vec demonstrates oncolytic and immunotherapeutic mechanisms of action. But the determinants of resistance to Pexa-Vec are mostly unknown. We treated hemoatologic malignant cells with Pexa-Ve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Nam Hee, Kim, Mikyung, Oh, Sung Yong, Kim, Seong-Geun, Kwon, Hyuk-Chan, Hwang, Tae-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352049/ https://www.ncbi.nlm.nih.gov/pubmed/27901484 http://dx.doi.org/10.18632/oncotarget.13598

Ejemplares similares

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
por: Chen, Nanhai, et al.
Publicado: (2013)

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
por: Innao, Vanessa, et al.
Publicado: (2020)

Effect of aldosterone on the amplification of oncolytic vaccinia virus in human cancer lines
por: Lee, Hyun Ju, et al.
Publicado: (2011)

The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
por: Sarodaya, Neha, et al.
Publicado: (2020)

Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy
por: Lee, Jeongsoo, et al.
Publicado: (2020)

Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes
por: Cho, Euna, et al.
Publicado: (2020)

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus
por: Cho, Euna, et al.
Publicado: (2018)

The premier statistical report of hematologic malignancies in Korea
por: Kim, Hee-Je
Publicado: (2012)

Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021)

Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer
por: Oh, Joowon, et al.
Publicado: (2021)

The Utility of the Multiplex Reverse Transcriptase-Polymerase Chain Reaction Assay in the Detection of Hematologic Malignancies
por: Kim, Min Jin, et al.
Publicado: (2013)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
por: Oh, Chang-Myung, et al.
Publicado: (2020)

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
por: Islam, S. M. Bakhtiar Ul, et al.
Publicado: (2020)

The Relationship Between Hematological Malignancy and Lipid Profile
por: Ozturk, Erman
Publicado: (2021)

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
por: Li, Qingbo, et al.
Publicado: (2022)

Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies
por: Rhee, Chin Kook, et al.
Publicado: (2009)

Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies
por: Kang, Hye Seon, et al.
Publicado: (2015)

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
por: Han, Eunhee, et al.
Publicado: (2014)

Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer
por: Lee, Seoyul, et al.
Publicado: (2022)

Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX
por: Oh, Sung Yong, et al.
Publicado: (2016)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Urolithiasis in Patients Suffering from Malignant Hematologic Diseases
por: Kim, Sae Woong, et al.
Publicado: (2010)

The oncolytic effects of reovirus in canine solid tumor cell lines
por: IGASE, Masaya, et al.
Publicado: (2015)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
por: Kimpel, Janine, et al.
Publicado: (2018)

Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors
por: de Sostoa, Jana, et al.
Publicado: (2020)

Analysis of bone marrow supernatant neutrophil gelatinase‐associated lipocalin and hematological parameters in hematological malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2020)

Gene Expression Profiling of Breast Cancers with Emphasis of β-Catenin Regulation
por: Roh, Mee Sook, et al.
Publicado: (2004)

Inonotosis in Patient with Hematologic Malignancy
por: Fernández-Cruz, Ana, et al.
Publicado: (2018)

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer
por: Kim, Do-Kyong, et al.
Publicado: (2009)

Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies
por: Kim, Heyjin, et al.
Publicado: (2019)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis
por: Jo, Hyun Ho, et al.
Publicado: (2020)

Clinical characteristics and outcomes of varicella zoster virus infection in children with hematologic malignancies in the acyclovir era
por: Kim, Seul-Ki, et al.
Publicado: (2016)

Anxiety and Depression of the Patients with Hematological Malignancies during Hospitalization for Hematopoietic Stem Cell Transplantation
por: Seo, Ho-Jun, et al.
Publicado: (2019)

Oncolytic virotherapy for pediatric malignancies: future prospects
por: Waters, Alicia M, et al.
Publicado: (2016)

Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022)

Predictors of stent dysfunction in patients with bilateral metal stents for malignant hilar obstruction
por: So, Hoonsub, et al.
Publicado: (2021)

Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
por: Suh, Hyeon Jeong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2iucvrb82kq4svidmdjpbmt8sg